Fei Liao
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Molecular Biology top 5%
- Porphyrin Metabolism and Disorders
- Biochemical and Molecular Research
- Protein purification and stability
- Advanced biosensing and bioanalysis techniques
Papers in
- Nephrology 16
- Gout, Hyperuricemia, Uric Acid 16
- Co-authors
- Xiaolan YangYunsheng ZhaoWeiguo DongYonghua YuanJun PuChang‐Guo ZhanXiaohong LüYanling Xie
- Journals
- Journal of Enzyme Inhibition and Medicinal Chemistry (4 papers)Analytica Chimica Acta (4 papers)Journal of Zhejiang University SCIENCE B (4 papers)Molecules (3 papers)Applied Biochemistry and Biotechnology (3 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Fei Liao
196 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 150
- Nephrology 240
- Molecular Biology 1.3k
- Cancer Research 240
- Pharmacology 112
- Cell Biology 174
Countries citing papers authored by Fei Liao
This map shows the geographic impact of Fei Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Liao more than expected).
Fields of papers citing papers by Fei Liao
This network shows the impact of papers produced by Fei Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Liao. The network helps show where Fei Liao may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 15 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 10 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 7 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 19 | |
| 13 | A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients | 2019 | 2 |
| 14 | 2017 | 79 | |
| 15 | 2017 | 1 | |
| 16 | 2016 | 6 | |
| 17 | 2014 | 14 | |
| 18 | Knowledge Stickiness,Knowledge Transfer and Countermeasure | 2007 | 1 |
| 19 | 2007 | 16 | |
| 20 | The Photosynthetic Response of Phoebe bournei to Doubled CO_2 Concentration in Air | 2003 | 3 |
About Fei Liao
Fei Liao is a scholar working on Fuel Technology, Nephrology, Molecular Biology, Biochemistry and Cell Biology, having authored 211 papers that have together received 2.7k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (16 papers), Porphyrin Metabolism and Disorders (16 papers), Biochemical and Molecular Research (15 papers), Protein purification and stability (10 papers), Biotin and Related Studies (9 papers), Advanced biosensing and bioanalysis techniques (7 papers), Insect Pest Control Strategies (7 papers) and Plant Toxicity and Pharmacological Properties (7 papers). The work is most often cited by research in Nephrology (240 citations), Molecular Biology (1.3k citations), Cancer Research (240 citations), Pharmacology (112 citations) and Cell Biology (174 citations). Fei Liao has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xiaolan Yang, Yunsheng Zhao, Weiguo Dong, Yonghua Yuan, Jun Pu, Chang‐Guo Zhan, Xiaohong Lü, Yanling Xie, Wei Lü and Huidong Yuan. Their work appears in journals such as Journal of Enzyme Inhibition and Medicinal Chemistry, Analytica Chimica Acta, Journal of Zhejiang University SCIENCE B, Molecules and Applied Biochemistry and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.